These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8429118)

  • 61. Antipyrine elimination in patients with obstructive jaundice: a predictor of outcome.
    McPherson GA; Benjamin IS; Boobis AR; Blumgart LH
    Am J Surg; 1985 Jan; 149(1):140-3. PubMed ID: 3966630
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Pharmacokinetics of encainide in patients with cirrhosis.
    Wensing G; Mönig H; Ohnhaus EE; Hoensch HP
    Cardiovasc Drugs Ther; 1991 Aug; 5(4):733-9. PubMed ID: 1909559
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Treatment of primary biliary cirrhosis with low-dose weekly methotrexate.
    Kaplan MM; Knox TA
    Gastroenterology; 1991 Nov; 101(5):1332-8. PubMed ID: 1936805
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Treatment of pruritus in primary biliary cirrhosis with rifampin. Results of a double-blind, crossover, randomized trial.
    Ghent CN; Carruthers SG
    Gastroenterology; 1988 Feb; 94(2):488-93. PubMed ID: 3275568
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Tissue zinc status and drug elimination in patients with chronic liver disease.
    Barry M; Keeling PW; Feely J
    Clin Sci (Lond); 1990 Jun; 78(6):547-9. PubMed ID: 2165886
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Primary biliary cirrhosis in Israel.
    Ilan Y; Shouval D
    Isr J Med Sci; 1992 Oct; 28(10):683-7. PubMed ID: 1356948
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Pharmacokinetics of antipyrine in calves during first 35 days of life.
    Janus K; Baranow-Baranowski S; Jakubowska D; Jankowiak D; Skrzypczak WF
    Arch Vet Pol; 1992; 32(1-2):75-81. PubMed ID: 1308711
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Antipyrine clearance: prognostic marker for obstructive jaundice.
    Nazareth HM; Rege NN; Nayak VK; Desai NK; Someshwar V; Dahanukar SA; Bapat RD
    Indian J Gastroenterol; 1990 Jan; 9(1):63-6. PubMed ID: 2307503
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The effect of propranolol on paracetamol metabolism in man.
    Baraka OZ; Truman CA; Ford JM; Roberts CJ
    Br J Clin Pharmacol; 1990 Feb; 29(2):261-4. PubMed ID: 2306420
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Impairment of drug elimination in patients with liver disease.
    Narang AP; Datta DV; Mathur VS
    Int J Clin Pharmacol Ther Toxicol; 1985 Jan; 23(1):28-32. PubMed ID: 3988389
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Effects of cirrhosis on kinetics of aztreonam.
    MacLeod CM; Bartley EA; Payne JA; Hudes E; Vernam K; Devlin RG
    Antimicrob Agents Chemother; 1984 Oct; 26(4):493-7. PubMed ID: 6542764
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Effects of subchronic treatment with natural human interferons on antipyrine clearance and liver function in patients with chronic hepatitis.
    Echizen H; Ohta Y; Shirataki H; Tsukamoto K; Umeda N; Oda T; Ishizaki T
    J Clin Pharmacol; 1990 Jun; 30(6):562-7. PubMed ID: 2113064
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Effect of zinc supplementation on oxidative drug metabolism in patients with hepatic cirrhosis.
    Barry MG; Macmathuna P; Younger K; Keeling PW; Feely J
    Br J Clin Pharmacol; 1991 Apr; 31(4):488-91. PubMed ID: 2049261
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Seasonal variations of antipyrine pharmacokinetics parameters in calves.
    Janus K; Baranow-Baranowski S; Jakubowska D; Jankowiak D; Skrzypczak WF
    Arch Vet Pol; 1992; 32(1-2):67-73. PubMed ID: 1308709
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Antipyrine clearance in surgical patients maintained on hypocaloric peripheral parenteral nutrition.
    Jorquera F; Almar M; Martinez C; Gonzalez-Sastre M; Culebras JM; Gonzalez-Gallego J
    JPEN J Parenter Enteral Nutr; 1994; 18(6):544-8. PubMed ID: 7602731
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Pharmacokinetics of famotidine after intravenous administration in liver disease.
    Ohnishi K
    Am J Gastroenterol; 1991 Jan; 86(1):41-5. PubMed ID: 1986553
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Plasma pharmacokinetics of adriamycin and antipyrine and its relation to the therapeutic and toxic effects.
    Preiss R; Matthias M; Sohr R; Brockmann B; Hüller H
    Int J Clin Pharmacol Ther Toxicol; 1985 Apr; 23 Suppl 1():S79-88. PubMed ID: 3842695
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Defective Fc receptor-mediated clearance in patients with primary biliary cirrhosis.
    Ekdahl KN; Lööf L; Nyberg A; Nilsson UR; Nilsson B
    Gastroenterology; 1991 Oct; 101(4):1076-82. PubMed ID: 1889700
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The pharmacokinetics and pharmacodynamics of hydroxyzine in patients with primary biliary cirrhosis.
    Simons FE; Watson WT; Chen XY; Minuk GY; Simons KJ
    J Clin Pharmacol; 1989 Sep; 29(9):809-15. PubMed ID: 2572611
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Antipyrine metabolism and liver function in patients treated with high-dose medroxyprogesterone.
    Rautio A; Kauppila AJ; Tuimala RJ; Sotaniemi EA
    Biomedicine; 1979 Sep; 31(5):135-8. PubMed ID: 508896
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.